Shizuoka, Japan

Naoto Oku

USPTO Granted Patents = 5 


Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 30(Granted Patents)


Location History:

  • Hirakata, JP (1992)
  • Shizuoka, JP (2012 - 2024)

Company Filing History:


Years Active: 1992-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Naoto Oku: Innovator in Synthetic Polymer Technology

Introduction

Naoto Oku is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of synthetic polymers, particularly in the development of innovative solutions for medical applications. With a total of five patents to his name, Oku's work focuses on improving the efficacy and affordability of treatments for various diseases.

Latest Patents

One of Oku's latest patents is the Abiotic anti-VEGF nanoparticle. This invention relates to compositions and methods that utilize abiotic, synthetic polymers with a specific affinity for proteins. These synthetic polymers offer a simpler, less expensive, and customizable platform for binding to proteins compared to traditional biological agents. The compositions are particularly useful for treating diseases associated with the overexpression of vascular endothelial growth factor (VEGF), including cancer. Additionally, these compositions can be employed to detect VEGF levels in biological samples and diagnose cancer.

Career Highlights

Throughout his career, Naoto Oku has worked with notable organizations, including Nippon Fine Chemical Co., Ltd. and the University of California. His experience in these institutions has allowed him to refine his expertise in synthetic polymer technology and its applications in medicine.

Collaborations

Oku has collaborated with esteemed colleagues such as Kenneth J. Shea and Hiroyuki Koide. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Naoto Oku's innovative work in synthetic polymers has the potential to revolutionize treatments for diseases related to VEGF overexpression. His contributions to the field highlight the importance of continued research and development in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…